Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Recent increased identification and transmission of HIV-1 unique recombinant forms in Sweden.

Neogi U, Siddik AB, Kalaghatgi P, Gisslén M, Bratt G, Marrone G, Sönnerborg A.

Sci Rep. 2017 Jul 25;7(1):6371. doi: 10.1038/s41598-017-06860-2.

2.

Overview of HIV molecular epidemiology among people who inject drugs in Europe and Asia.

Nikolopoulos GK, Kostaki EG, Paraskevis D.

Infect Genet Evol. 2016 Dec;46:256-268. doi: 10.1016/j.meegid.2016.06.017. Epub 2016 Jun 7. Review.

PMID:
27287560
3.
4.

Ultra-Deep Sequencing of HIV-1 near Full-Length and Partial Proviral Genomes Reveals High Genetic Diversity among Brazilian Blood Donors.

Pessôa R, Loureiro P, Esther Lopes M, Carneiro-Proietti AB, Sabino EC, Busch MP, Sanabani SS.

PLoS One. 2016 Mar 31;11(3):e0152499. doi: 10.1371/journal.pone.0152499. eCollection 2016.

5.

Can HIV reverse transcriptase activity assay be a low-cost alternative for viral load monitoring in resource-limited settings?

Gupta S, Palchaudhuri R, Neogi U, Srinivasa H, Ashorn P, De Costa A, Källander C, Shet A.

BMJ Open. 2016 Jan 27;6(1):e008795. doi: 10.1136/bmjopen-2015-008795.

6.

Geographic origin and evolutionary history of China's two predominant HIV-1 circulating recombinant forms, CRF07_BC and CRF08_BC.

Feng Y, Takebe Y, Wei H, He X, Hsi JH, Li Z, Xing H, Ruan Y, Yang Y, Li F, Wei J, Li X, Shao Y.

Sci Rep. 2016 Jan 14;6:19279. doi: 10.1038/srep19279.

7.

Characteristics and spread to the native population of HIV-1 non-B subtypes in two European countries with high migration rate.

Dauwe K, Mortier V, Schauvliege M, Van Den Heuvel A, Fransen K, Servais JY, Bercoff DP, Seguin-Devaux C, Verhofstede C.

BMC Infect Dis. 2015 Nov 16;15:524. doi: 10.1186/s12879-015-1217-0.

8.

Subtype-independent near full-length HIV-1 genome sequencing and assembly to be used in large molecular epidemiological studies and clinical management.

Grossmann S, Nowak P, Neogi U.

J Int AIDS Soc. 2015 Jun 25;18:20035. doi: 10.7448/IAS.18.1.20035. eCollection 2015.

9.

HIV Epidemic in Asia: Implications for HIV Vaccine and Other Prevention Trials.

Phanuphak N, Lo YR, Shao Y, Solomon SS, O'Connell RJ, Tovanabutra S, Chang D, Kim JH, Excler JL.

AIDS Res Hum Retroviruses. 2015 Nov;31(11):1060-76. doi: 10.1089/aid.2015.0049. Epub 2015 Jun 24. Review.

10.

High HIV burden among people who inject drugs in 15 Indian cities.

Lucas GM, Solomon SS, Srikrishnan AK, Agrawal A, Iqbal S, Laeyendecker O, McFall AM, Kumar MS, Ogburn EL, Celentano DD, Solomon S, Mehta SH.

AIDS. 2015 Mar 13;29(5):619-28. doi: 10.1097/QAD.0000000000000592.

11.

Mutations in the reverse transcriptase and protease genes of human immunodeficiency virus-1 from antiretroviral naïve and treated pediatric patients.

Bure D, Makhdoomi MA, Lodha R, Prakash SS, Kumar R, Parray HA, Singh R, Kabra SK, Luthra K.

Viruses. 2015 Feb 10;7(2):590-603. doi: 10.3390/v7020590.

12.

The gp120 protein is a second determinant of decreased neurovirulence of Indian HIV-1C isolates compared to southern African HIV-1C isolates.

Rao VR, Neogi U, Eugenin E, Prasad VR.

PLoS One. 2014 Sep 4;9(9):e107074. doi: 10.1371/journal.pone.0107074. eCollection 2014.

13.

Development, validation and clinical evaluation of a low cost in-house HIV-1 drug resistance genotyping assay for Indian patients.

Acharya A, Vaniawala S, Shah P, Misra RN, Wani M, Mukhopadhyaya PN.

PLoS One. 2014 Aug 26;9(8):e105790. doi: 10.1371/journal.pone.0105790. eCollection 2014.

14.

Temporal trends in the Swedish HIV-1 epidemic: increase in non-B subtypes and recombinant forms over three decades.

Neogi U, Häggblom A, Santacatterina M, Bratt G, Gisslén M, Albert J, Sonnerborg A.

PLoS One. 2014 Jun 12;9(6):e99390. doi: 10.1371/journal.pone.0099390. eCollection 2014.

15.

Molecular epidemiology of HIV-1 in Panama: origin of non-B subtypes in samples collected from 2007 to 2013.

Mendoza Y, Bello G, Castillo Mewa J, Martínez AA, González C, García-Morales C, Avila-Ríos S, Reyes-Terán G, Pascale JM.

PLoS One. 2014 Jan 13;9(1):e85153. doi: 10.1371/journal.pone.0085153. eCollection 2014.

16.

Phylogenetic characterization of six full-length HIV-1 subtype C molecular clones from three patients: identification of rare subtype C strains containing two NF-κB motifs in the long terminal repeat.

Hanna LE, Neogi U, Ranga U, Swaminathan S, Prasad VR.

AIDS Res Hum Retroviruses. 2014 Jun;30(6):586-91. doi: 10.1089/AID.2013.0275. Epub 2014 Feb 7.

17.

Phylogenetic inferences on HIV-1 transmission: implications for the design of prevention and treatment interventions.

Brenner B, Wainberg MA, Roger M.

AIDS. 2013 Apr 24;27(7):1045-57. doi: 10.1097/QAD.0b013e32835cffd9. Review. No abstract available.

18.

Future of phylogeny in HIV prevention.

Brenner BG, Wainberg MA.

J Acquir Immune Defic Syndr. 2013 Jul;63 Suppl 2:S248-54. doi: 10.1097/QAI.0b013e3182986f96.

19.

Clade C HIV-1 isolates circulating in Southern Africa exhibit a greater frequency of dicysteine motif-containing Tat variants than those in Southeast Asia and cause increased neurovirulence.

Rao VR, Neogi U, Talboom JS, Padilla L, Rahman M, Fritz-French C, Gonzalez-Ramirez S, Verma A, Wood C, Ruprecht RM, Ranga U, Azim T, Joska J, Eugenin E, Shet A, Bimonte-Nelson H, Tyor WR, Prasad VR.

Retrovirology. 2013 Jun 8;10:61. doi: 10.1186/1742-4690-10-61.

20.

Human APOBEC3G-mediated hypermutation is associated with antiretroviral therapy failure in HIV-1 subtype C-infected individuals.

Neogi U, Shet A, Sahoo PN, Bontell I, Ekstrand ML, Banerjea AC, Sonnerborg A.

J Int AIDS Soc. 2013 Feb 25;16:18472. doi: 10.7448/IAS.16.1.18472.

Supplemental Content

Support Center